EP Patent

EP2064234B1 — Bioactive peptides and method of using same

Assigned to Compugen Ltd · Expires 2011-11-02 · 15y expired

What this patent protects

Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.

USPTO Abstract

Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2064234B1
Jurisdiction
EP
Classification
—
Expires
2011-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Compugen Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.